Clinical Fellow H-1B salary at Dana Farber Cancer Institute — 38 certified filings (FY2017–FY2026)
- 6
- Filings · FY2025
- $93k
- Median base · FY2025
- $91k–$105k
- Middle 50% · FY2025
- +6%
- vs market median · all years
Dana Farber Cancer Institute filed 6 certified H-1B LCAs for Clinical Fellow in FY2025, with a median base salary of $93k and the middle 50% of offers between $91k and $105k. Across all years its $89k median is 6% above the $84k market median for Clinical Fellow. It has filed 38 Clinical Fellow LCAs since FY2017, most often in Boston, MA.
How much does Dana Farber Cancer Institute pay a Clinical Fellow?
Certified base salary for Clinical Fellow at Dana Farber Cancer Institute by fiscal year: each box is the p25–p75 range, the heavy line the median, the whiskers reach p10–p90. $93k median in FY2025. Base pay only — hover a year for its figures.
Does Dana Farber Cancer Institute pay Clinical Fellows above the market?
Dana Farber Cancer Institute's all-years median against every employer's certified Clinical Fellow LCAs — 6% above the market. Same cleaned DOL title, same base-salary definition, so the two rows compare like for like.
| Base salary for this title | Filings | Median |
|---|---|---|
| Dana Farber Cancer Institute | 38 | $89k |
| All employers · Clinical Fellow | 1,725 | $84k |
How has Dana Farber Cancer Institute's Clinical Fellow hiring changed by year?
1 certified Clinical Fellow filings in FY2017 → 8 in FY2026. The change column is each year against the one before.
| Fiscal year | Filings | vs prior FY | Median base |
|---|---|---|---|
| FY2026 | 8 | +33% | $95k |
| FY2025 | 6 | +20% | $93k |
| FY2024 | 5 | +67% | $89k |
| FY2023 | 3 | −25% | $86k |
| FY2022 | 4 | +100% | $87k |
| FY2021 | 2 | −71% | $79k |
| FY2020 | 7 | +250% | $78k |
| FY2019 | 2 | +100% | $73k |
| FY2017 | 1 | — | $72k |
Which wage levels does Dana Farber Cancer Institute file for Clinical Fellow?
DOL prevailing-wage levels I–IV approximate experience tiers (I = entry, IV = fully competent). 0% of Dana Farber Cancer Institute's Clinical Fellow filings sit at Level III–IV. Higher levels earn more entries in the wage-weighted H-1B lottery.
Share of 9 Clinical Fellow filings with a wage level · all years
- Level I100.0%9
Where does Dana Farber Cancer Institute hire H-1B Clinical Fellows?
Worksite states and cities on the certified filings for this title, all years, with the median base salary at each.
| State | Filings | Median base |
|---|---|---|
| Massachusetts | 38 | $89k |
| City | Filings | Median base |
|---|---|---|
| Boston, MA | 37 | $90k |
| Norton, MA | 1 | $78k |
Also filed as
Dana Farber Cancer Institute's other sponsored titles, and the employers that file the most Clinical Fellow LCAs. All years.
Other titles at Dana Farber Cancer Institute
| Job title | Filings | Median base |
|---|---|---|
| Research Fellow | 562 | $63k |
| Research Technician | 48 | $44k |
| Scientist | 40 | $78k |
| Statistician | 39 | $93k |
| Sr. Research Technician | 32 | $47k |
| Instructor (Scientist) | 31 | $82k |
Top Clinical Fellow sponsors
| Employer | Filings | Median base |
|---|---|---|
| Brigham and Women’s Hospital | 335 | $84k |
| Memorial Sloan-kettering Cancer Center | 300 | $93k |
| Children S Hospital | 156 | $89k |
| Massachusetts General Physicians Organization | 127 | $95k |
| National Institutes of Health Hhs | 122 | $85k |
| The University of Tennessee Health Science Center | 99 | $73k |
| Cincinnati Children S Hospital Medical Center | 64 | $74k |
| Massachusetts General Physician S Organization | 63 | $80k |
| Vanderbilt University Medical Center | 45 | $70k |
| Beth Israel Deaconess Medical Center | 39 | $76k |
Common questions about Clinical Fellow H-1B pay at Dana Farber Cancer Institute
- How much does Dana Farber Cancer Institute pay a Clinical Fellow on an H-1B?
- Dana Farber Cancer Institute's median certified H-1B base salary for Clinical Fellow is $93k in FY2025, from 6 filings; the middle 50% of offers fall between $91k and $105k. Across all years the median is $89k.
- How many Clinical Fellow H-1B LCAs has Dana Farber Cancer Institute filed?
- Dana Farber Cancer Institute has 38 certified H-1B Labor Condition Applications for Clinical Fellow on record (FY2017–FY2026), 8 of them in FY2026. That is 3% of its 1,180 certified filings across all titles.
- Does Dana Farber Cancer Institute pay Clinical Fellows above the market?
- Dana Farber Cancer Institute's all-years median of $89k is 6% above the $84k median for Clinical Fellow across all H-1B employers (1,725 certified filings).
- Where does Dana Farber Cancer Institute hire H-1B Clinical Fellows?
- Dana Farber Cancer Institute's Clinical Fellow LCAs name worksites mostly in Massachusetts; the top cities are Boston, MA, Norton, MA.
- Does a certified LCA mean an H-1B visa was approved?
- No. A Labor Condition Application (LCA) is the Department of Labor attestation an employer must have certified before filing an H-1B petition with USCIS. It records the job, worksite and offered wage, but not whether the petition was filed, selected in the lottery, or approved. Filing counts measure intent to sponsor, not headcount.
- What salary do these figures show?
- The base annual wage offered on the certified LCA, converted to a yearly amount. Bonus, equity, overtime and benefits are not included, so total compensation is typically higher. Figures are medians and percentiles over certified filings; wages above $5,000,000 a year are excluded as data-entry errors.
- What do prevailing-wage levels I–IV mean?
- The Department of Labor assigns each LCA an OES wage level from I (entry) to IV (fully competent) for the occupation and area. Under the FY2027 wage-weighted H-1B lottery rule, a higher level earns more selection entries, so an employer's level mix is a proxy for how senior its sponsored roles are.
Keep exploring
Calculate your H-1B lottery odds →orCheck out the insights →
Source: U.S. Department of Labor, Office of Foreign Labor Certification — certified LCA disclosure data through June 2026 (FY2017–FY2026). An LCA is not an approved visa; pay figures are base salary and exclude bonus and equity. Methodology →